Correlation Between Aerovate Therapeutics and Maptelligent

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aerovate Therapeutics and Maptelligent at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aerovate Therapeutics and Maptelligent into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aerovate Therapeutics and Maptelligent, you can compare the effects of market volatilities on Aerovate Therapeutics and Maptelligent and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aerovate Therapeutics with a short position of Maptelligent. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aerovate Therapeutics and Maptelligent.

Diversification Opportunities for Aerovate Therapeutics and Maptelligent

-0.55
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Aerovate and Maptelligent is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding Aerovate Therapeutics and Maptelligent in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Maptelligent and Aerovate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aerovate Therapeutics are associated (or correlated) with Maptelligent. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Maptelligent has no effect on the direction of Aerovate Therapeutics i.e., Aerovate Therapeutics and Maptelligent go up and down completely randomly.

Pair Corralation between Aerovate Therapeutics and Maptelligent

Given the investment horizon of 90 days Aerovate Therapeutics is expected to generate 6.13 times less return on investment than Maptelligent. But when comparing it to its historical volatility, Aerovate Therapeutics is 2.12 times less risky than Maptelligent. It trades about 0.02 of its potential returns per unit of risk. Maptelligent is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  0.04  in Maptelligent on September 14, 2024 and sell it today you would lose (0.03) from holding Maptelligent or give up 75.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Aerovate Therapeutics  vs.  Maptelligent

 Performance 
       Timeline  
Aerovate Therapeutics 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Aerovate Therapeutics are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile basic indicators, Aerovate Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.
Maptelligent 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Maptelligent has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Aerovate Therapeutics and Maptelligent Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aerovate Therapeutics and Maptelligent

The main advantage of trading using opposite Aerovate Therapeutics and Maptelligent positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aerovate Therapeutics position performs unexpectedly, Maptelligent can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Maptelligent will offset losses from the drop in Maptelligent's long position.
The idea behind Aerovate Therapeutics and Maptelligent pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Other Complementary Tools

Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Commodity Directory
Find actively traded commodities issued by global exchanges
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk